Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,788 | -51,844 | -135,688 | -65,538 | -223,938 |
| Depreciation Amortization | 2,996 | 2,199 | 1,446 | 717 | 1,869 |
| Accounts receivable | -299 | 1,141 | 1,141 | 365 | 2,710 |
| Accounts payable and accrued liabilities | -7,636 | -2,330 | -8,488 | -6,851 | 19,932 |
| Other Working Capital | -159,214 | -138,920 | 14,629 | -15,810 | 91,115 |
| Other Operating Activity | 39,396 | 24,101 | 23,255 | 10,801 | 322 |
| Operating Cash Flow | $-252,545 | $-165,653 | $-103,705 | $-76,316 | $-107,990 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,515 | -2,949 | -2,449 | -2,148 | -6,164 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -785 |
| Investing Cash Flow | $-6,515 | $-2,949 | $-2,449 | $-2,148 | $-6,949 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 100,000 | 100,000 | 100,000 | 100,000 | N/A |
| Common Stock Issued | 126,918 | 71,429 | 364 | 298 | 1,429 |
| Other Financing Activity | -739 | -1,249 | 68,562 | -455 | 121,260 |
| Financing Cash Flow | $226,179 | $170,180 | $168,926 | $99,843 | $122,689 |
| Exchange Rate Effect | -398 | -127 | -82 | -47 | 84 |
| Beginning Cash Position | 159,071 | 158,226 | 158,226 | 158,226 | 150,392 |
| End Cash Position | 125,792 | 159,677 | 220,916 | 179,558 | 158,226 |
| Net Cash Flow | $-33,279 | $1,451 | $62,690 | $21,332 | $7,834 |
| Free Cash Flow | |||||
| Operating Cash Flow | -252,545 | -165,653 | -103,705 | -76,316 | -107,990 |
| Capital Expenditure | -6,515 | -2,949 | -2,449 | -2,148 | -6,164 |
| Free Cash Flow | -259,060 | -168,602 | -106,154 | -78,464 | -114,154 |